bioAffinity Technologies, Inc. · NASDAQ:BIAF
Hrt Financial LP bought 138,244 and sold 162,219 bioAffinity Technologies, Inc. shares (Form 4)
Traded Sep 22 to Oct 1, 2026 · Filed Nov 19, 2026
From Sep 22 to Oct 1, 2026, Hrt Financial LP (10% owner) bought 138,244 and sold 162,219 bioAffinity Technologies, Inc. shares, leaving 116,658 shares. Filed Nov 19, 2026 (Form 4).
- Bought
- 138,244 shares (US$1.04M at an average US$7.52)
- Sold
- 162,219 shares (US$1.18M at an average US$7.24)
- Holding after
- 116,658 shares
- Trading plan
- No
- Role
- 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 22, 2026 | Common Stock | Buy | 18,929 | US$8.59 | 126,519 | Direct |
| Sep 22, 2026 | Common Stock | Sale | 7,077 | US$8.63 | 126,519 | Direct |
| Sep 23, 2026 | Common Stock | Buy | 7,509 | US$7.91 | 128,884 | Direct |
| Sep 23, 2026 | Common Stock | Buy | 11,002 | US$8.14 | 128,884 | Direct |
| Sep 23, 2026 | Common Stock | Sale | 11,129 | US$7.94 | 128,884 | Direct |
| Sep 23, 2026 | Common Stock | Sale | 10,859 | US$8.11 | 128,884 | Direct |
| Sep 24, 2026 | Common Stock | Buy | 30,065 | US$7.67 | 131,221 | Direct |
| Sep 24, 2026 | Common Stock | Sale | 27,246 | US$7.76 | 131,221 | Direct |
| Sep 25, 2026 | Common Stock | Buy | 7,271 | US$7.81 | 126,037 | Direct |
| Sep 25, 2026 | Common Stock | Sale | 9,111 | US$7.86 | 126,037 | Direct |
| Sep 28, 2026 | Common Stock | Buy | 10,734 | US$7.64 | 127,533 | Direct |
| Sep 28, 2026 | Common Stock | Buy | 2 | US$8.09 | 127,533 | Direct |
| Sep 28, 2026 | Common Stock | Sale | 13,856 | US$7.57 | 127,533 | Direct |
| Sep 28, 2026 | Common Stock | Sale | 152 | US$8.10 | 127,533 | Direct |
| Sep 29, 2026 | Common Stock | Buy | 8,894 | US$6.86 | 134,741 | Direct |
| Sep 29, 2026 | Common Stock | Buy | 13,840 | US$7.12 | 134,741 | Direct |
| Sep 29, 2026 | Common Stock | Sale | 18,627 | US$6.83 | 134,741 | Direct |
| Sep 29, 2026 | Common Stock | Sale | 2,201 | US$7.05 | 134,741 | Direct |
| Sep 30, 2026 | Common Stock | Buy | 12,125 | US$6.78 | 126,146 | Direct |
| Sep 30, 2026 | Common Stock | Sale | 20,432 | US$6.76 | 126,146 | Direct |
| Oct 1, 2026 | Common Stock | Buy | 17,873 | US$6.54 | 116,658 | Direct |
| Oct 1, 2026 | Common Stock | Sale | 41,529 | US$6.45 | 116,658 | Direct |
Source
Download original · View original at SEC